<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=35476375865279447&ev=PageView&noscript=1"/>

Glenmark Pharmaceuticals Limited

NSE: GLENMARK · Lot size: 375

OverviewOption ChainOI AnalysisFII / DIIMax Pain

Glenmark Pharmaceuticals Limited FII & DII Activity

FII Net (₹ Cr)
-1,059.93
Buy 12,756.88 · Sell 13,816.81
DII Net (₹ Cr)
+2,966.89
Buy 18,753.06 · Sell 15,786.17
FII F&O Net (contracts)
+0
Index + stock futures

5-Day Flow Trend

DateFII Net (₹ Cr)DII Net (₹ Cr)
2026-04-21-1,059.93+2,966.89
2026-04-20+683.2-4,721.48
2026-04-18+683.2-4,721.48
AI AnalysisGenerated daily after market close · AI-powered

Today's Institutional Flow

Foreign Institutional Investors (FII) sold ₹1059.93 Cr in cash, reflecting risk reduction amid global headwinds. Domestic Institutional Investors (DII) strongly offset this with ₹2966.89 Cr in net purchases, signaling domestic confidence. No FII or DII participation was observed in futures and options.

Trend vs 5-Day Average

Today’s FII outflow marks a reversal from their 5-day average inflow of ₹683.2 Cr, indicating short-term caution. DIIs, despite a negative 5-day average of ₹4721.48 Cr, returned with heavy buying, breaking recent selling momentum.

F&O Positioning Signal

FII did not take new positions in F&O, with no contract activity recorded today. Their index futures long/short ratio stands at 1.2, suggesting moderate bullish sentiment on broader markets despite sector-specific caution.

Implication for Finance

Sustained DII buying in pharma, countered by FII profit-booking, may stabilize Glenmark and support sector resilience tomorrow.

Market-wide FII/DII data — same for all F&O stocks. Date: 2026-04-21

Related Analysis

Same Sector

ABB
ABB India Limited
Neutral
ABCAPITAL
Aditya Birla Capital Limited
Neutral
ADANIENSOL
Adani Energy Solutions Limited
Neutral
ADANIENT
Adani Enterprises Limited
Neutral
ADANIGREEN
Adani Green Energy Limited
Neutral

Frequently Asked Questions

What is FII net buying/selling in Glenmark Pharmaceuticals Limited today?▾
FII (Foreign Institutional Investor) net flow in the Indian cash market today is ₹1,059.93 Cr (net selling) as of 2026-04-21. This market-wide figure applies to all F&O stocks including Glenmark Pharmaceuticals Limited.
What is DII activity in Glenmark Pharmaceuticals Limited today?▾
DII (Domestic Institutional Investors — mutual funds, insurance companies) net flow is ₹2,966.89 Cr (net buying) today. DIIs often act as a counterbalancing force to FII flows — on days when FIIs sell, DIIs typically provide support.
What is FII F&O net for Glenmark Pharmaceuticals Limited today?▾
FII net F&O position (index + stock futures combined) is +0 contracts as of the latest participant OI data. A positive number means FIIs are net long in futures; negative means net short.
Were there any block deals in Glenmark Pharmaceuticals Limited?▾
Block deal data for Glenmark Pharmaceuticals Limited is tracked daily from NSE's block deal window. On days with activity, the deal value in ₹ Crore is shown on this page.
How does FII/DII data affect Glenmark Pharmaceuticals Limited stock price?▾
FII and DII flows are market-wide data — all F&O stocks including Glenmark Pharmaceuticals Limited are influenced. When FIIs buy heavily (positive net), it typically supports the broader market. When FII F&O net is strongly positive (long futures), it signals institutional conviction in an uptrend. Combined with Glenmark Pharmaceuticals Limited's individual OI buildup type, this provides a directional framework.